Literature DB >> 15174514

Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery.

Christoph Mamot1, John B Nguyen, Micheal Pourdehnad, Piotr Hadaczek, Ryuta Saito, John R Bringas, Daryl C Drummond, Keelung Hong, Dmitri B Kirpotin, Tracy McKnight, Mitchel S Berger, John W Park, Krys S Bankiewicz.   

Abstract

Liposomes labeled with various markers were subjected to local-regional administration with either direct injection or convection-enhanced delivery (CED) into rodent brains and brain tumor models. Direct injection of liposomes containing attached or encapsulated fluorochromes and/or encapsulated gold particles indicated that tissue localization of liposomes could be sensitively and specifically detected in the central nervous system (CNS). When CED was applied, liposomes achieved extensive and efficient distribution within normal mouse brains. Co-infusion of mannitol further increased tissue penetration of liposomes. Liposomes were also loaded with gadodiamide to monitor their CNS distribution in rats by magnetic resonance imaging (MRI). CED-infused liposomes were readily seen on MRI scans as large regions of intense signal at 2 h, and more diffuse regions at 24 h. Finally, labeled liposomes were infused via CED into tumor tissue in glioma xenograft models in rodent hosts. In intracranial U-87 glioma xenografts, CED-infused liposomes had distributed throughout tumor tissue, including extension into surrounding normal tissue. Greater penetration was observed using 40 versus 90 nm liposomes, as well as with mannitol co-infusion. To our knowledge, this is the first report of CED infusion of liposomes into the CNS. We conclude that CED of liposomes in the CNS is a feasible approach, and offers a promising strategy for targeting therapeutic agents to brain tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174514     DOI: 10.1023/b:neon.0000024743.56415.4b

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

Review 1.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Authors:  D C Drummond; O Meyer; K Hong; D B Kirpotin; D Papahadjopoulos
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

3.  Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.

Authors:  K S Bankiewicz; J L Eberling; M Kohutnicka; W Jagust; P Pivirotto; J Bringas; J Cunningham; T F Budinger; J Harvey-White
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

4.  Convection-enhanced delivery into the rat brainstem.

Authors:  David I Sandberg; Mark A Edgar; Mark M Souweidane
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

5.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes.

Authors:  F Szoka; F Olson; T Heath; W Vail; E Mayhew; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1980-10-02

6.  Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.

Authors:  Weilian Yang; Rolf F Barth; Dianne M Adams; Michael J Ciesielski; Robert A Fenstermaker; Supriya Shukla; Werner Tjarks; Michael A Caligiuri
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

7.  Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin.

Authors:  J F Hamilton; P F Morrison; M Y Chen; J Harvey-White; R S Pernaute; H Phillips; E Oldfield; K S Bankiewicz
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

8.  Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

Authors:  Christoph Mamot; Daryl C Drummond; Udo Greiser; Keelung Hong; Dmitri B Kirpotin; James D Marks; John W Park
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

Authors:  F Yuan; M Leunig; S K Huang; D A Berk; D Papahadjopoulos; R K Jain
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

10.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.

Authors:  D C Litzinger; A M Buiting; N van Rooijen; L Huang
Journal:  Biochim Biophys Acta       Date:  1994-02-23
View more
  49 in total

1.  Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts.

Authors:  Laura P Serwer; Charles O Noble; Karine Michaud; Daryl C Drummond; Dmitri B Kirpotin; Tomoko Ozawa; Michael D Prados; John W Park; C David James
Journal:  Neuro Oncol       Date:  2011-09-27       Impact factor: 12.300

Review 2.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

Review 3.  Real-time imaging and quantification of brain delivery of liposomes.

Authors:  Michal T Krauze; John Forsayeth; John W Park; Krystof S Bankiewicz
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

4.  Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex.

Authors:  Conor P Foley; Nozomi Nishimura; Keith B Neeves; Chris B Schaffer; William L Olbricht
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

Review 5.  Drug transport to brain with targeted liposomes.

Authors:  Anita Schnyder; Jörg Huwyler
Journal:  NeuroRx       Date:  2005-01

Review 6.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

7.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

8.  The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.

Authors:  Neal Luther; Zhiping Zhou; Pat Zanzonico; Nai-Kong Cheung; John Humm; Mark A Edgar; Mark M Souweidane
Journal:  Neuro Oncol       Date:  2014-02-12       Impact factor: 12.300

Review 9.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

10.  Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Authors:  Emilie Allard; Delphine Jarnet; Anne Vessières; Sandrine Vinchon-Petit; Gérard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2009-11-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.